Literature DB >> 10201895

Naive human CD4+ T cells are a major source of lymphotoxin alpha.

Y Ohshima1, L P Yang, M N Avice, M Kurimoto, T Nakajima, M Sergerie, C E Demeure, M Sarfati, G Delespesse.   

Abstract

It is generally accepted that immunologically naive T cells display a very restricted cytokine production profile consisting mainly of IL-2, which is used as an autocrine growth factor. Here we report that activated naive CD4+ T cells, of neonatal or adult origin, express very high levels of soluble lymphotoxin (LT) alpha (LTalpha3), as determined by ELISA, RNase protection assay, and intracytoplasmic staining. Besides LTalpha3 and IL-2, these cells also produce high levels of TNF-alpha together with significant amounts of IFN-gamma and IL-13. Naive cells also express LTbeta mRNA and the membrane form of LTalpha (LTalphabeta). On average, naive CD4+ T cells secrete four times more LTalpha3 than Th1-like cells, twice more than naive CD8+ T cells, and ten times more than B cells. Thus, naive T cells express a large spectrum of cytokines, mainly of the Th1 type, and the very high levels of LTalpha3/TNF-alpha that they release may play an hitherto unsuspected role in the early stage of T cell-dependent immune responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201895

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  LIGHT-related molecular network in the regulation of innate and adaptive immunity.

Authors:  Yanhui Xu; Koji Tamada; Lieping Chen
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

2.  Multi-color flow cytometry for evaluating age-related changes in memory lymphocyte subsets in dogs.

Authors:  Sita S Withers; Peter F Moore; Hong Chang; Jin W Choi; Stephen J McSorley; Michael S Kent; Arta M Monjazeb; Robert J Canter; William J Murphy; Ellen E Sparger; Robert B Rebhun
Journal:  Dev Comp Immunol       Date:  2018-05-31       Impact factor: 3.636

3.  A stimulation-dependent alternate core promoter links lymphotoxin α expression with TGF-β1 and fibroblast growth factor-7 signaling in primary human T cells.

Authors:  Brian H Yokley; Sandra T Selby; Phillip E Posch
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

Review 4.  Keystones in lymph node development.

Authors:  Katrin S Blum; Reinhard Pabst
Journal:  J Anat       Date:  2006-11       Impact factor: 2.610

Review 5.  Lymphotoxin organizes contributions to host defense and metabolic illness from innate lymphoid cells.

Authors:  Vaibhav Upadhyay; Yang-Xin Fu
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-24       Impact factor: 7.638

6.  Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution.

Authors:  Ming Zeng; Mirko Paiardini; Jessica C Engram; Greg J Beilman; Jeffrey G Chipman; Timothy W Schacker; Guido Silvestri; Ashley T Haase
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

7.  Human Naive T Cells Express Functional CXCL8 and Promote Tumorigenesis.

Authors:  Joel Crespo; Ke Wu; Wei Li; Ilona Kryczek; Tomasz Maj; Linda Vatan; Shuang Wei; Anthony W Opipari; Weiping Zou
Journal:  J Immunol       Date:  2018-05-25       Impact factor: 5.422

8.  Regulation of T-cell function by endogenously produced angiotensin II.

Authors:  Nyssa E Hoch; Tomasz J Guzik; Wei Chen; Tenecia Deans; Samer A Maalouf; Petra Gratze; Cornelia Weyand; David G Harrison
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-10       Impact factor: 3.619

9.  CD4+CD45RBHi interleukin-4 defective T cells elicit antral gastritis and duodenitis.

Authors:  Taeko Dohi; Kohtaro Fujihashi; Toshiya Koga; Yuri Etani; Naoto Yoshino; Yuki I Kawamura; Jerry R McGhee
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

10.  Induction of lymphotoxin-alpha by interleukin-12 p40 homodimer, the so-called biologically inactive molecule, but not IL-12 p70.

Authors:  Malabendu Jana; Kalipada Pahan
Journal:  Immunology       Date:  2008-11-14       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.